The role of NADPH oxidases in diabetic cardiomyopathy

Synne S Hansen1, Ellen Aasum1, Anne D Hafstad1

  • 1Cardiovascular Research Group, Department of Medical Biology, Faculty of Health Sciences, UIT-The Arctic University of Tromsø, N-9037 Tromsø, Norway.

Insights

Diabetic cardiomyopathy involves oxidative stress from enzymes like NADPH-oxidases (NOXs). This review explores how NOXs impact heart changes in diabetes, suggesting them as potential therapeutic targets.

Area of Science:

  • Cardiovascular Research
  • Metabolic Diseases
  • Oxidative Stress Biology

Background:

  • Diabetes induces cardiomyocyte structural and functional changes, leading to diabetic cardiomyopathy.
  • Increased oxidative stress, particularly via reactive oxygen species (ROS), is a key feature of the diabetic heart.
  • NADPH-oxidases (NOXs) are significant ROS-producing enzymes in cardiomyocytes, influencing cardiac adaptation and maladaptation.

Purpose of the Study:

  • To review current knowledge on the role of NOXs in diabetic cardiomyopathy.
  • To elucidate how NOXs mediate adaptive and maladaptive cardiac processes within a diabetic environment.
  • To assess the therapeutic potential of targeting NOXs in diabetic heart complications.

Main Methods:

  • Literature review of existing studies on NOXs and diabetic cardiomyopathy.
  • Analysis of research on ROS production by NOXs in cardiomyocytes.
  • Synthesis of findings on the impact of NOXs on cardiac structure and function in diabetes.

Main Results:

  • NOXs contribute significantly to oxidative stress in the diabetic heart.
  • NOX enzymes play a dual role, mediating both beneficial and detrimental cardiac changes in diabetes.
  • The precise mechanisms by which NOXs influence diabetic cardiomyopathy require further investigation.

Conclusions:

  • NOXs are critical players in the pathophysiology of diabetic cardiomyopathy.
  • Understanding NOX function in the diabetic milieu is essential for developing targeted therapies.
  • Further research is warranted to fully elucidate NOX pathways for therapeutic intervention in diabetic heart disease.

Related Concept Videos

Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
17.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
805
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K